P

Inventor

ZHANG PENGLIE

US126 patents
⚠️ This page may combine multiple inventors who share the name “ZHANG PENGLIE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CHEMOCENTRYX INC

36 patents
US10639284B2May 5, 2020

Immunomodulator compounds

CHEMOCENTRYX INC17 citations94
US9834545B2Dec 5, 2017

Modulators of chemokine receptors

CHEMOCENTRYX INC26 citations94
US9809581B2Nov 7, 2017

Inhibitors of CXCR2

CHEMOCENTRYX INC23 citations94
US9169261B2Oct 27, 2015

CXCR7 antagonists

CHEMOCENTRYX INC13 citations92
US7790726B2Sep 7, 2010

Monocyclic and bicyclic compounds and methods of use

CHEMOCENTRYX INC34 citations92
US7776877B2Aug 17, 2010

N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides

CHEMOCENTRYX INC11 citations92
US7629344B2Dec 8, 2009

3-(imidazolyl)-pyrazolo[3,4-b]pyridines

CHEMOCENTRYX INC13 citations92
US7589199B2Sep 15, 2009

Substituted piperazines

CHEMOCENTRYX INC18 citations92
US9745268B2Aug 29, 2017

Processes and intermediates in the preparation of C5aR antagonists

CHEMOCENTRYX INC11 citations91
US11485708B2Nov 1, 2022

Compounds for treatment of PD-L1 diseases

CHEMOCENTRYX INC9 citations86
US11426364B2Aug 30, 2022

Immunomodulator compounds

CHEMOCENTRYX INC10 citations86
US11266643B2Mar 8, 2022

Triaryl compounds for treatment of PD-L1 diseases

CHEMOCENTRYX INC13 citations86
US11135210B2Oct 5, 2021

Indane-amines as PD-L1 antagonists

CHEMOCENTRYX INC10 citations86
US10568874B2Feb 25, 2020

Indane-amines as PD-L1 antagonists

CHEMOCENTRYX INC13 citations86
US10562896B2Feb 18, 2020

6-5 fused rings as C5a inhibitors

CHEMOCENTRYX INC11 citations86
US11713307B2Aug 1, 2023

Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases

CHEMOCENTRYX INC8 citations85
US11059834B2Jul 13, 2021

Macrocyclic immunomodulators

CHEMOCENTRYX INC10 citations85
US10919852B2Feb 16, 2021

Immunomodulator compounds

CHEMOCENTRYX INC15 citations85
US11384079B2Jul 12, 2022

6-5 fused rings as C5a inhibitors

CHEMOCENTRYX INC5 citations84
US10828285B2Nov 10, 2020

Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors

CHEMOCENTRYX INC5 citations84
US10759807B2Sep 1, 2020

Diaryl substituted 5,5-fused ring compounds as C5aR inhibitors

CHEMOCENTRYX INC7 citations84
US10683294B2Jun 16, 2020

5-5 fused rings as C5a inhibitors

CHEMOCENTRYX INC8 citations84
US10532982B2Jan 14, 2020

Processes and intermediates in the preparation of C5aR antagonists

CHEMOCENTRYX INC4 citations84
US10487098B2Nov 26, 2019

Soluble C5aR antagonists

CHEMOCENTRYX INC6 citations84
US10464934B2Nov 5, 2019

Substituted tetrahydropyrans as CCR2 modulators

CHEMOCENTRYX INC5 citations84
US10392405B2Aug 27, 2019

Macrocyclic immunomodulators

CHEMOCENTRYX INC13 citations84
US10370363B2Aug 6, 2019

Inhibitors of CXCR2

CHEMOCENTRYX INC6 citations84
US10336736B2Jul 2, 2019

Modulators of chemokine receptors

CHEMOCENTRYX INC6 citations84
US10329314B2Jun 25, 2019

Soluble C5aR antagonists

CHEMOCENTRYX INC12 citations84
US10266492B2Apr 23, 2019

Processes and intermediates in the preparation of C5aR antagonists

CHEMOCENTRYX INC8 citations84
US9783540B2Oct 10, 2017

Substituted tetrahydropyrans as CCR2 modulators

CHEMOCENTRYX INC7 citations84
US9783544B2Oct 10, 2017

CXCR7 antagonists

CHEMOCENTRYX INC4 citations84
US9750722B2Sep 5, 2017

Diazole amides

CHEMOCENTRYX INC5 citations84
US9328116B2May 3, 2016

Diazole lactams

CHEMOCENTRYX INC4 citations84
US9169248B2Oct 27, 2015

Diazole amides

CHEMOCENTRYX INC6 citations84
US8916601B2Dec 23, 2014

Aza-aryl 1H-pyrazol-1-YL benzene sulfonamides

CHEMOCENTRYX INC12 citations84

MILLENNIUM PHARM INC

11 patents

ZHU BING-YAN

2 patents

COR THERAPEUTICS INC

1 patent

Showing the top 50 of 126 patents by PatentIndex Score.